Wharton's Jelly Derived Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Wharton's Jelly Derived Mesenchymal Stem Cells, covering 2019-03-08 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment [Phase 1, Phase 2]